<DOC>
	<DOC>NCT00758537</DOC>
	<brief_summary>Tryptophan metabolism in kidney disease will be investigated in patients with chronic kidney disease stages (ADOQI 3-5). Tryptophan levels and respective catabolites will be assessed under hemodialysis.</brief_summary>
	<brief_title>Tryptophan Metabolism in Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Tryptophan</mesh_term>
	<criteria>Chronic kidney disease (for &gt; 3months) stages (National Kidney foundation/ADOQI): 35 Signs of infection or systemic inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease</keyword>
</DOC>